인면역결핍 바이러스 pol 유전자 염기서열 결정에 의한 지도부딘 (ZDV) 내성 돌연변이의 탐지

Detection of Mutations to Zidovudine in the pol Gene of Human Immunodeficiency Virus-1 by Direct Sequencing

  • 조영걸 (울산대학교 의과대학 미생물학교실) ;
  • 이희정 (울산대학교 의과대학 미생물학교실) ;
  • 성흥섭 (울산대학교 의과대학 미생물학교실) ;
  • 김유겸 (울산대학교 의과대학 미생물학교실) ;
  • 김영봉 (울산대학교 의과대학 미생물학교실) ;
  • 이용진 (아산생명과학연구소) ;
  • 김미정 (아산생명과학연구소) ;
  • 김대곤 (전북대학교 의과대학 내과학교실) ;
  • 원영호 (전남대학교 의과대학 피부과학교실) ;
  • 조군제 (부산대학교 의과대학 내과학교실)
  • Cho, Young-Keol (Department of Microbiology, University of Ulsan College of Medicine) ;
  • Lee, Hee-Jung (Department of Microbiology, University of Ulsan College of Medicine) ;
  • Sung, Heung-Sup (Department of Microbiology, University of Ulsan College of Medicine) ;
  • Kim, Yoo-Kyum (Department of Microbiology, University of Ulsan College of Medicine) ;
  • Kim, Young-Bong (Department of Microbiology, University of Ulsan College of Medicine) ;
  • Lee, Yong-Jin (Asan Institute for Life Sciences) ;
  • Kim, Mi-Jung (Asan Institute for Life Sciences) ;
  • Kim, Dae-Ghon (Department of Internal Medicine, Chonbuk National University Hospital) ;
  • Won, Young-Ho (Department of Dermatology, Chonnam National University Hospital) ;
  • Cho, Goon-Jae (Department of Internal Medicine, Pusan National University Hospital)
  • 발행 : 1999.12.30

초록

The nested polymerase chain reaction (PCR) assay was used to determine the sequences of reverse transcriptase (RT) codons 41, 67, 70, 210, 215 and 219 of human immunodeficiency virus-1 (HIV-1) pol gene. Template DNA was obtained from uncultured peripheral blood mononuclear cells from 27 Korean HIV-1 infected patients treated with ZDV and Korean red ginseng. The second PCRs were done for 2 separated regions (RT codons $13{\sim}98$ and $152{\sim}259$) with $5\;{\mu}l$ of the first PCR productNucleotide sequences were determined by direct sequencing. In the 27 patients, CD4+ cell count decreased from $230{\pm}117/{\mu}l$ to $152{\pm}162/{\mu}l$ for $46{\pm}26$ months (Mo), and actual duration of ZDV intake was $72{\pm}16$ Mo. In the 16 patients who had been treated with ZDV therapy ${\ge}25$ Mo, the incidences of 70R, 215F/Y, and 41L were 61%, 28% and 22%, respectively and those of 67N, 210W and 219Q were 17%. The incidences of 215F/Y were 6.7% for group ${\le}12$ Mo treatment, 22.7% for group with 13 to 24 Mo, and 27.8% for group ${\ge}25$ Mo. There was no mutation in 9 patients. It might be associated with the interruption of ZDV therapy for more than 6 months in 6 patients. This study shows that the detection of mutation could be useful prognostic marker with other clinical and virological data, and very low mutation rate is dectected compared to overseas reports.

키워드